FDA Issues Updated Details on Class I Recall of Zen Principle Naturals Moringa Leaf Powder
An ongoing Class I recall covers 2,048 bottles of Zen Principle Naturals Moringa Leaf Powder capsules due to possible Salmonella contamination.
4 reports on this incident · first at Aug 18, 2026, 12:08 p.m. ET
This recall is open. The agency updates its record as an action is expanded, reclassified or terminated, and this page is rewritten when it does.
We last searched for new coverage of this at Aug 18, 2026, 8:14 a.m. ET — checked 5h ago.
Earlier reports
Aug 18, 2026, 1:08 p.m. ET
FDA Classifies Ongoing Recall of Zen Principle Naturals Moringa Leaf Powder as Class I
On August 12, 2026, an official FDA enforcement report classified the ongoing recall of Zen Principle Naturals Moringa Leaf Powder dietary supplement as Class I. According to FDA definitions, Class I is the agency's most serious classification, used when there is a reasonable probability that using the product will cause serious harm or death. The recall, under recall number H-1222-2026, was initiated on July 19, 2026, due to possible Salmonella in the product.
The recall covers 2,048 bottles of Zen Principle Naturals Moringa Leaf Powder dietary supplement in 900mg capsules, packaged as 180 capsules per PET white bottle. Manufactured by FACTORY6, INC. for Zen Principle, the recall applies to LOT code A6FF4 with a Best By date of 11/2028. The product is offered as a 1-pack with 180 capsules (Amazon code/FNSKU X000ZJJ4FT) and as a 2-pack twin pack with 360 capsules (Amazon code/FNSKU X00159YJXP). Official records state the product was distributed to Nevada for further distribution, and the recall status is ongoing.
According to the FDA, Salmonella is a bacterium that causes salmonellosis. Most people develop diarrhoea, fever and abdominal cramps between 12 and 72 hours after infection, with illness usually lasting four to seven days. The FDA states that severe cases can require hospitalisation, with young children, older adults and people with weakened immune systems at greatest risk. FDA database records show no other enforcement actions for FACTORY6, INC.
Aug 18, 2026, 12:54 p.m. ET
FDA Declares Recall of Zen Principle Moringa Leaf Powder Capsules Closed
On August 12, 2026, the U.S. Food and Drug Administration updated its record on the recall of Zen Principle Naturals Moringa Leaf Powder dietary supplement capsules, marking the action as closed. The closure indicates that the agency considers the recall to have been carried out. The recall was originally initiated on July 19, 2026, by FACTORY6, INC. under recall number H-1222-2026.
For consumers who may still hold the product, the recall covers 2,048 bottles of Zen Principle Naturals Moringa Leaf Powder dietary supplement, 900mg capsules, packaged as 180 capsules per PET white bottle. The recall applies to products marked with lot code LOT: A6FF4 and a Best By date of 11/2028. The product was manufactured for Zen Principle, 774 Mays Blvd Incline Village, NV 89451, and distributed to Nevada for further distribution. It was offered as a 1-pack (180 capsules; Amazon code/FNSKU X000ZJJ4FT) and as a 2-pack twin pack (360 capsules; Amazon code/FNSKU X00159YJXP).
According to an FDA enforcement report, the recall was initiated due to possible Salmonella in the Moringa Leaf Powder product. The agency designated the action as Class I, its most serious category, applied when there is a reasonable probability that using the product will cause serious harm or death. The FDA states that Salmonella is a bacterium that causes salmonellosis, with most people developing diarrhoea, fever and abdominal cramps between 12 and 72 hours after infection. The agency reports illness usually lasts four to seven days, though severe cases require hospitalisation, with young children, older adults and people with weakened immune systems at greatest risk.
FDA database records show no other enforcement action associated with FACTORY6, INC. Across the past two years, 433 food recalls in the agency's database cite Salmonella.
Aug 18, 2026, 12:08 p.m. ETFirst report
FDA Classifies Recall of Zen Principle Naturals Moringa Leaf Powder Capsules as Class I
On August 12, 2026, an official FDA enforcement report recorded an ongoing, developing Class I recall of 2,048 bottles of Zen Principle Naturals Moringa Leaf Powder dietary supplement. The recall was initiated on July 19, 2026, by FACTORY6, INC. Under FDA definitions, Class I is the agency's most serious recall category, reserved for situations where there is a reasonable probability that using the product will cause serious harm or death.
The recall covers Zen Principle Naturals Moringa Leaf Powder dietary supplement, 900mg capsules, packaged as 180 capsules per PET white bottle, with identifying lot code A6FF4 and a Best By date of 11/2028. The product was manufactured for Zen Principle at 774 Mays Blvd Incline Village, NV 89451, and distributed to Nevada for further distribution. It was offered as a 1-pack (180 capsules; Amazon code/FNSKU X000ZJJ4FT) and a 2-pack twin pack (360 capsules; Amazon code/FNSKU X00159YJXP). According to reference entries from Britannica, iNaturalist, Feedipedia, and ECHOcommunity, moringa leaf powder is derived from dried, milled leaves of the Moringa oleifera tree.
The FDA enforcement report lists the reason for the recall as possible Salmonella in the product. The FDA states that Salmonella causes salmonellosis, with symptoms of diarrhoea, fever, and abdominal cramps developing between 12 and 72 hours after infection and lasting four to seven days. The agency notes that severe cases can require hospitalisation, with young children, older adults, and individuals with weakened immune systems facing the greatest risk. Agency records show no other enforcement actions for FACTORY6, INC., while 433 food recalls in the FDA database over the past two years cite Salmonella.
Was this report accurate and useful?
Sources
Revision history
- Version 118 Aug 2026, 17:24current
First published.
- Version 118 Aug 2026, 16:08current
First published.
- Version 118 Aug 2026, 17:08current
First published.
- Version 118 Aug 2026, 16:54current
First published.
How we work
This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.
Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.
Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.
None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.